Clinical Trials Sponsored by Neoimmune Technologies

Total 1836 results

MedImmune LLC

Completed

Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD)

Graft-Versus-Host Disease

United States
MedImmune LLC

Completed

Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)

Influenza

United States
MedImmune LLC

Completed

Long-Term Follow-Up Study of Psoriasis Patients

Psoriasis

Canada, United States, Belgium, France, Germany, Netherlands
MedImmune LLC

Withdrawn

A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia
MedImmune LLC

Completed

Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524

Respiratory Syncytial Virus Infections

Chile, Argentina
MedImmune LLC

Completed

Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)

Influenza

United States
MedImmune LLC

Completed

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children

Influenza
MedImmune LLC

Completed

Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

Influenza

United States
MedImmune LLC

Completed

Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)

Lupus

United States, Canada
MedImmune LLC

Completed

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Influenza

United States
MedImmune LLC

Completed

Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants

Healthy

United States
MedImmune LLC

Completed

Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

Rheumatoid Arthritis

United States, Canada
MedImmune LLC

Completed

Study to Evaluate MEDI-534 in Healthy Adults

Respiratory Syncytial Virus Infections | Parainfluenza Infections

United States
MedImmune LLC

Terminated

Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease

Lymphoproliferative Disorders

United States
MedImmune LLC

Completed

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Healthy | Influenza

United States
Enimmune Corporation

Enrolling by invitation

A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children

Enterovirus Infections

Taiwan, Vietnam
Epimmune
Pharmexa A/S; Pharmexa-Epimmune

Unknown

A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) (EP1090)

HIV Infections

United States
Enimmune Corporation

Completed

A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects

Enterovirus Infections

Taiwan
DBV Technologies
Todd D. Green MD, DBV Technologies

Available

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Peanut Allergy

United States
Retropsoas Technologies, LLC

Not yet recruiting

A Post-marketing Study to Evaluate a Novel Surgical Monitoring Technique Using the EARP Nerve Cuff in TLIF Surgery.

Undergoing a Single-level or Two-level TLIF Surgery

United States
Gradient Denervation Technologies

Recruiting

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study) (PreVail-PH2)

Heart Failure | Group 2 Pulmonary Hypertension

United States
NovaResp Technologies Inc

Recruiting

Airway Muscle Activation on Sleep-disordered Breathing Events

Sleep Apnea

Canada
Gradient Denervation Technologies

Recruiting

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension (PreVail-PH)

Heart Failure Patients With Pulmonary Hypertension

Georgia
Silq Technologies Corporation

Recruiting

Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention

Catheter Infection | Catheter Blockage | Catheter Related Complication | Catheter Calcification

United States
GATT Technologies BV

Recruiting

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Liver Diseases | Gallbladder Diseases | Intraoperative Bleeding | Hemorrhage, Surgical

United States
BLIS Technologies Limited

Recruiting

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Microbial Colonization

New Zealand
BLIS Technologies Limited

Recruiting

Colonisation Efficacy of a Probiotic Chewing Gum.

Microbial Colonization

New Zealand
BLIS Technologies Limited

Recruiting

Colonisation Efficacy of Oral Probiotic Fast Melt Powder

Microbial Colonization

New Zealand
Umbria Bioengineering Technologies

Recruiting

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

Breast Cancer

Spain, Italy
Neonc Technologies, Inc.

Recruiting

NEO100 and High-Grade Meningioma

Residual, Progressive or Recurrent Grade II or III Meningioma

United States
Umbria Bioengineering Technologies

Recruiting

Clinical Investigation to Evaluate the Suitability of StrokeWave in Distinguishing Haemorragic From Ischaemic Strokes

Stroke, Ischemic | Stroke Hemorrhagic

Italy
Valent Technologies, LLC

Recruiting

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Ewing Sarcoma | Medulloblastoma | Neuroblastoma | Solid Tumors | Rhabdomyosarcoma | Hepatoblastoma

United States
Palatin Technologies, Inc

Recruiting

Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects

Heart Failure With Preserved Ejection Fraction

United States
Awareable Technologies Inc

Recruiting

Low Level Light Therapy (LLLT) for Hair Growth

Male Pattern Baldness | Female Pattern Baldness

United States
bioAffinity Technologies Inc.

Recruiting

Collection of Sputum and Labeling for Lung Cancer

Lung Cancer

United States
Neonc Technologies, Inc.

Recruiting

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

Glioblastoma Multiforme

United States
Pharming Technologies B.V.

Recruiting

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

Germany, Bulgaria, Croatia, Czechia, France, Hungary, Italy, North Macedonia, Poland, Slovakia, Norway, Slovenia, Sweden
Pharming Technologies B.V.

Terminated

Prevention of Acute Kidney Injury in Patients With NSTEMI (AKI)

Non-ST Elevation Myocardial Infarction (NSTEMI)

Switzerland
Pharming Technologies B.V.

Active, not recruiting

Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Activated PI3Kdelta Syndrome (APDS); PASLI Disease

United States, Belarus, Czechia, Germany, Italy, Netherlands, Russian Federation
BrainQ Technologies Ltd.

Completed

The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE "EMAGINE" STUDY) (BQ5)

Ischemic Stroke

United States
DreamFace Technologies, LLC

Completed

Ryan Companion Robot for Assisting Elderly People With Alzheimer's Disease

Alzheimer Disease, Early Onset

United States
Pharming Technologies B.V.

Completed

Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Confirmed Coronavirus Disease

United States
Silq Technologies Corporation

Active, not recruiting

Randomized Study of Silq Urinary Catheter

UTI | Biofilm Formation

United States
MedCu Technologies Ltd.

Terminated

Efficacy of Wound Dressings With Copper Oxide

Diabetic Foot Ulcer | Pressure Ulcer

Israel
MedCu Technologies Ltd.

Completed

Comparison of Wound Healing Between MedCu Dressings With Copper Oxide and Negative Pressure Wound Therapy Treatment

Wounds and Injuries | Diabetic Foot Ulcer | Negative Pressure Therapy

Israel
Laminate Medical Technologies

Completed

VasQ External Support for Arteriovenous Fistula

Diabetes Mellitus | Renal Failure | ESRD | Aneurysm | Kidney Failure | Renal Disease | Arterio-Venous Fistula | Steal Syndrome

United States
ESM Technologies, LLC

Completed

Pilot Study of the Efficacy & Safety of Natural Eggshell Membrane (NEM) for Joint & Connective Tissue Disorders

Osteoarthritis | Fibromyalgia

United States
bioAffinity Technologies Inc.

Completed

Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer

Lung Cancer

United States
Liberating Technologies, Inc.

Withdrawn

Evaluation of Dexterous Terminal Device

Amputation | Prosthesis User | Amputation; Traumatic, Hand | Amputation, Traumatic | Upper Limb Amputation at the Hand | Upper Limb Amputation Below Elbow (Injury) | Limb; Absence, Congenital, Upper
iRhythm Technologies, Inc.

Completed

Extended ECG Monitoring in HCM Patients (EXAMINE-HCM)

Atrial Fibrillation | Arrhythmia | Ventricular Tachycardia | Hypertrophic Cardiomyopathy | Nonsustained Ventricular Tachycardia

United States

Clinical Trials Sponsored by Neoimmune Technologies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations